ARK Genomic Revolution ETF vs Riot Platforms Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while Riot Platforms Inc trades at $20.7 (market cap $7.93B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Riot Platforms Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | RIOT | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $28.67 |
52-Week Low | $23.09 | $11.03 |
Market Cap | — | $7.93B |
Enterprise Value | — | $8.60B |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
RIOT trades at $20.97, down 2.58% today, with a bearish technical signal. Recent earnings show mixed results, beating in Q3 2025 but missing in Q4 2025 and Q1 2026. The company reported a net loss of $663 million in 2025 despite $647 million revenue. Analyst consensus is strongly bullish with a $27.86 price target. News highlights volatility tied to Bitcoin trends and a strategic pivot toward AI data centers.
Outlook remains speculative with high valuation multiples amid persistent losses. Opportunities include expansion into high-performance computing, but risks involve cash flow deficits, competitive pressures, and sensitivity to cryptocurrency markets. Investors should weigh analyst optimism against fundamental challenges.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Riot Platforms, Inc. is a Bitcoin mining company that focuses on building, operating, and expanding large-scale infrastructure for digital asset mining in North America. The company's operations include Bitcoin mining, data center hosting, and engineering solutions. Riot's strategy emphasizes vertical integration to maximize efficiency and scale its mining capacity, aiming to be a leader in the global Bitcoin and digital infrastructure industry.
Read more on RIOT →